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Abstract
Bluetongue virus (BTV) is the cause of bluetongue, an emerging, arthropod-transmitted disease of
ungulates. Bluetongue is characterized by vascular injury with hemorrhage, tissue infarction and
widespread edema, lesions that are consistent with those of the so-called viral hemorrhagic fevers.
To further investigate the pathogenesis of vascular injury in bluetongue, we utilized an electrical
impedance assay and immunofluorescence staining to compare the effects of BTV infection on
cultured bovine endothelial cells (bPAEC) with those of inducers of cell death (Triton X-100) and
interendothelial gap formation (tissue necrosis factor [TNF]). The data confirm that the adherens
junctions of BTV-infected bPAECs remained intact until 24 hours post-infection, and that loss of
monolayer impedance precisely coincided with onset of virus-induced cell death. In contrast,
recombinant bovine TNF-α caused rapid loss of bPAEC monolayer impedance that was associated
with interendothelial gap formation and redistribution of VE-cadherin, but without early cell death.
The data from these in vitro studies are consistent with a pathogenesis of bluetongue that involves
virus-induced vascular injury leading to thrombosis, hemorrhage and tissue necrosis. However, the
contribution of cytokine-induced interendothelial gap formation with subsequent edema and
hypovolemic shock contributes to the pathogenesis of bluetongue remains to be fully characterized.
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1. Introduction
Bluetongue virus ([BTV]; genus Orbivirus, family Reoviridae) and related orbiviruses such as
African horse sickness virus are the cause of important and apparently emerging arboviral
diseases of livestock (Backx et al., 2007; Burrage and Laegreid, 1994; Coetzer and Guthrie,
2004; Darpel et al., 2007; MacLachlan and Guthrie, 2010; Mellor and Hamblin, 2004;
Toussaint et al., 2007; Verwoerd and Erasmus, 2004). BTV infection of ruminants occurs
throughout tropical and temperate regions of the world, coincident with the distribution of
competent Culicoides insect vectors (Gibbs and Greiner, 1994; Pritchard et al., 2004;
Tabachnick, 2004). However, there has been a remarkable recent northern expansion of the
virus’ global range that has been attributed in part to the impact of climate change (Purse et
al., 2008; Purse et al., 2005; Wilson and Mellor, 2008). Bluetongue disease is most common
in certain breeds of sheep and species of wildlife, but some BTV strains also cause severe
disease in cattle, goats, South American camelids and other wild and domestic ungulates, and
even carnivores (Darpel et al., 2007; Jauniaux et al., 2008; Meyer et al., 2009; Verwoerd and
Erasmus, 2004).
Bluetongue is characterized by hemorrhage and ulceration of the oral cavity and upper
gastrointestinal tract; facial, intermuscular and pulmonary edema; peritoneal, pleural and
pericardial effusion; coronitis; necrosis of skeletal and cardiac muscle; and subintimal
hemorrhage in the pulmonary artery (MacLachlan et al., 2009). The gross and histopathologic
lesions of bluetongue are consistent with a pathogenesis that involves injury to small caliber
blood vessels, which in turn leads to increased permeability of affected vessels as well as
hemorrhage, thrombosis, and ischemic tissue necrosis (infarction) (Erasmus, 1975;
MacLachlan et al., 2008; Mahrt and Osburn, 1986; Moulton, 1961; Spreull, 1905; Verwoerd
and Erasmus, 2004). Vascular injury in bluetongue has been attributed to direct virus-mediated
injury to endothelial cells (EC), but recent findings suggest that the process of EC injury and
dysfunction may be more complex and be attributable, at least in part, to the activities of virus-
induced, host-derived inflammatory and vasoactive mediators (DeMaula et al., 2001; DeMaula
et al., 2002a; DeMaula et al., 2002b; Drew et al., 2010). These in vitro studies also clearly
demonstrated that the EC response, as measured by activation and various mechanisms of cell
death, is dependent on and modulated by the presence of proinflammatory mediators. Similarly,
lysates of BTV-infected ECs caused an immediate increase in the permeability of monolayers
of human ECs, as measured by a decrease in monolayer resistance and confirmed by
immunofluorescence labeling that showed redistribution of VE-cadherin, an adherens junction
protein of ECs that is important in maintaining monolayer integrity (Chiang et al., 2006).
However, crude lysates containing virus and soluble, cell derived mediators were used in these
latter experiments, which clearly confuses distinction of the relative roles of virus infection
versus mediator activity in modulating monolayer permeability.
The objective of this study was to further investigate the pathogenesis of bluetongue,
specifically the mechanisms by which BTV infection alters vascular permeability in susceptible
ruminants. An electrical impedance assay and fluorescence staining were used to characterize
the effect of BTV infection on cultured bovine ECs. The data show that the decrease in
impedance of BTV-infected bovine ECs occurs relatively late in the course of infection and
coincides with virus-induced cell death. In contrast, there was little change in monolayer
impedance prior to the onset of virus-induced cytopathology, whereas paracellular
permeability, as assessed by monolayer impedance and immunofluorescence labeling of VE-
cadherin, was altered rapidly by exposure to cytokine mediators such as tissue necrosis factor
(TNF).
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2. Materials and Methods
2.1. Cells
Baby hamster kidney (BHK-21) cells were obtained from ATCC (CCL-10). The isolation and
purification of the bovine pulmonary artery ECs (bPAEC) were described previously (DeMaula
et al., 2001). Cells were maintained in complete medium Dulbeco’s minimal essential medium
[(DMEM), Gibco, 10313-021], 10 % fetal bovine serum, MEM vitamins, non essential amino
acids, L- glutamine, sodium pyruvate (Gibco, 11360), and confluent monolayers of bPAECs
of similar passage number (9 or 10) were used in all experiments. The bPAEC were grown on
surfaces coated with 10 μg mL−1 human fibronectin (Gibco, 33016-015).
2.2. Antibodies and cytokines
A murine monoclonal antibody (MAb) specific for BTV core protein VP7 (MAb 290 ) has
been described previously (Whetter et al., 1989). Goat anti-VE-cadherin was obtained from
Santa Cruz Biotech (SCBT, SC-6458). AlexaFluor® 594 donkey anti-mouse IgG (Invitrogen,
A21203) and AlexaFluor® 488 donkey anti-goat IgG (Invitrogen, A11055) were used as
secondary antibodies, and AlexaFluor® 594 phalloidin (Invitrogen, A12381) was used to label
actin. Recombinant bovine TNF – α (rbTNF-α) (Thermo Scientific, RBOTNFAI) was
reconstituted and stored according to the manufacturer’s recommendations.
2.3. Virus and recombinant BTV proteins
The United States’ prototype strain of BTV serotype 10 (ATCC, VR-1231) was used for all
experiments. The virus inoculum was prepared by infecting BHK-21 cells until the appearance
of complete cytopathic effect. The cells were pelleted and sonicated for 2 minutes to release
cell associated virus, and the virus containing supernatants and cell lysates were centrifuged
at 400 g to remove the cellular debris from the virus suspension. The virus suspension was
then ultracentrifuged at 69,000 g through a 5 % sucrose cushion to separate BTV from soluble,
cell-derived mediators and the partially purified virus preparation was re-suspended in phenol
red - free DMEM (Gibco, 30153), aliquoted and frozen at −80 °C. Virus titers (TCID50) were
determined as previously described (Barratt-Boyes et al., 1992; MacLachlan et al., 1984).
Baculovirus-expressed individual BTV structural (VP) and nonstructural (NS) proteins (VP1,
VP2, VP4, VP5, VP6, VP7, NS1, and NS2) as well as core-like particles (co-expressed VP3/
VP7) were produced as previously described (French and Roy, 1990; Inumaru and Roy,
1987; Kar and Roy, 2003; Loudon and Roy, 1991; Oldfield et al., 1990; Stauber et al., 1997).
2.4. Kinetics of BTV infection of bPAEC
The kinetics of BTV infection of bPAECs were determined using both one-step growth curve
analysis and immunofluorescence staining of VP7 at 6-8 hour intervals after infection. Titers
of BTV (TCID50) were determined after infection of confluent monolayers of bPAECs in T25
flasks; virus (m.o.i. 1) was absorbed for 1 hour when the monolayer was washed with MEM
and complete medium was added. At each time point, cells were scraped from the flask and
the cell suspensions were sonicated for 2 minutes. The cell debris was removed by
centrifugation (400 g) and the titer (TCID50) of the virus suspension was determined by end
point dilution as described previously (DeMaula et al., 2001). bPAEC monolayers for
immunofluorescence staining were grown on sterile 12 mm coverslips, and infected with BTV
at an m.o.i. of 1. Monolayers were fixed at 6-8 hour intervals after infection with 4 %
paraformaldehyde, permeabilized with 0.01 % Triton X-100 (Fischer Scientific, BP151), then
incubated for 1 hour with MAb 290 diluted in PBS containing 1.5 % bovine serum albumin
(BSA), washed and then incubated with labeled donkey anti-mouse IgG for one hour, washed
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and mounted in Prolong gold with 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen,
P36935).
2.5. Impedance of bPAEC monolayers after cytokine treatment or BTV infection
The impedance across confluent monolayers of bPAECs was determined using a real-time cell
electronic sensor (RT-CES) system (Roche) that measures impedance of individual
monolayers over time in a 96-well plate format, where any decrease in impedance is equated
to a proportionate increase in monolayer permeability (Atienza et al., 2006; Kirstein et al.,
2006; Li et al., 2006). The measurement is reported as a Cell Index (CI). Impedance was
monitored in individual wells after addition of known inducers of either inter-endothelial gap
formation [rbTNF-α (0.1 μg/mL)] or cell death [Triton X-100 (0.1 % v/v)]. BTV was added
to confluent monolayers (m.o.i. 5), and individual recombinant BTV proteins at 125 ng
mL−1. The impedance of individual monolayers was monitored in 6 replicates every 30 minutes
after addition of TNF or Triton X-100, BTV, or individual recombinant BTV proteins until
completion of the experiment at 36 - 48 hours after exposure.
2.6. Cell cytotoxicity
The appearance of cell death in BTV-infected monolayers was evaluated by phase microscopy
at 0, 6, 12, 18, 24, 36, and 48 hours after BTV infection at an m.o.i. of 5. Cytotoxicity was also
objectively quantitated in a 96 – well format with a protease release assay (Promega, CytoTox-
Fluor, G9261), as directed by the manufacturer. Cytotoxicity was determined at 6 hours after
exposure of bPAEC to vehicle control, rbTNF – α, or Triton X-100, and at 0, 6, 12, 18, 24, and
36 hours after BTV infection at an m.o.i. of 5.
2.7 Dual labeling of VE-cadherin and actin or BTV
Confluent monolayers of bPAECs were grown in 24 – well culture plates containing sterilized
12 mm, round glass coverslips. Individual EC monolayers were treated for 6 hours with rbTNF-
α (0.1 μl mL−1) or vehicle control (complete EC medium), or were infected with BTV (m.o.i.
of 5). Post treatment or infection, monolayers were fixed with fresh 4 % paraformaldehyde,
permeabilized with 0.01 % Triton X-100, blocked with 10% BSA prior to immunofluorescence
staining for VE-cadherin and actin, or VE-cadherin and BTV core protein VP7. Individual
monolayers were incubated with goat anti - VE cadherin antibody and MAb 290 specific for
BTV core protein VP7 diluted in 1.5% BSA/PBS, followed by AlexaFluor® 488 donkey anti-
goat IgG and AlexaFluor® 594 donkey anti-mouse IgG. Actin was labeled with
AlexaFluor®594 rhodamine according to the manufacturer’s directions. The coverslips were
mounted on Fisher brand Superfrost plus slides with Prolong gold with DAPI. Fluorescence
was visualized with an Olympus BX61 equipped with a xenon lamp and appropriate fluorescent
filters.
2.8 Statistical analysis
Results are presented as mean ± SD. Treated samples were compared to controls by paired t-
tests. For multiple-group comparisons, ANOVA, followed by the Fisher’s LSD post hoc, was
used. For analysis of differences over time, repeated measures ANOVA, followed by the
Fisher’s LSD post hoc, was used. A p-value of < 0.05 was considered significant. For
correlation analysis, Spearman’s correlation was used to compare impedance and cytotoxicity.
3. Results
3.1. Virus growth in bPAECs
There was a substantial increase in virus titer following BTV infection of bPAECs, with a
marked increase by 12 hours after infection (Drew et al., 2010). Similarly, there was
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progressively increased intensity of immunofluorescence staining of BTV core protein VP7
(Fig. 1), with abundant cytoplasmic staining of VP7 in all cells by 12 hours after infection.
Prominent holes in the bPAEC monolayer were present by 24 hours after infection, consistent
with the obvious cytolysis and nuclear pyknosis and karyorrhexis that were concurrently
evident by phase contrast light microscopy (data not shown).
3.2. Impedance and cytotoxicity of bPAECs treated with inducers of cell death (Triton X-100)
and interendothelial gap formation (TNF – α)
The impedance of bPAEC monolayers was abolished immediately after treatment with Triton
X-100, and persisted thereafter (Fig. 2A). Similarly, cytotoxicity as assessed by protease
release was markedly and significantly increased following Triton X-100 treatment (Fig. 2C).
Thus, the decrease in monolayer impedance following Triton X-100 treatment is attributed to
cell death (Fig. 2D). The impedance of bPAEC monolayers treated with rbTNF – α was also
reduced for the duration of the experiment (Fig. 2B). Although the impedance of the rbTNF –
α treated monolayers was significantly decreased at 6 hours after exposure, there was no
difference at this time in the viability of the TNF-treated bPAEC monolayers, as determined
by protease release assay (Fig. 2C). It is concluded, therefore, that the early decrease in
impedance of rbTNF-treated bPAEC monolayers is attributable to interendothelial gap
formation and not cell death, as demonstrated by the redistribution of VE – cadherin with
formation of microscopically visible gaps between treated bPAECs (Fig. 2E).
3.3. The onset of reduced impedance of BTV-infected bPAEC monolayers coincides with cell
death
The impedance of BTV-infected bPAECs monolayers (m.o.i. 5) was significantly decreased
at 12 hours and thereafter (Fig. 3A). The incidence of cell death increased over time in the
BTV infected bPAEC monolayers as determined by both protease release assay and visual
observation using phase contrast microscopy. Increased cell death as determined by protease
release assay was first detected at 12 hours after BTV infection (m.o.i. 5), and was significantly
increased thereafter (Fig. 3B). Phase contrast microscopy confirmed that cell death began at
12 hours after infection and progressed over the next 36 hours to complete cytopathic effect
(Fig. 3C).
The correlation between impedance (pooled difference) and cytotoxicity (pooled ratios) at 0,
6, 12, 24, and 36 hours after infection was 0.917 (p < 0.01), confirming that the change in
impedance is strongly associated with an increased incidence of cell death within the infected
monolayers.
3.4. Adherens junctions remain intact in BTV- infected bPAECs
The effect of BTV infection on the adherens junctions of bPAEC monolayers was evaluated
over time by fluorescent labeling of VE-cadherin and BTV core protein VP7. Despite the
presence of abundant intracellular BTV antigen at 6 hours after infection and thereafter, there
was continuous staining of the adherens junctions of bPAECs in areas of intact monolayer at
12-18 hours after infection (Fig. 4), confirming that interendothelial junctions remained intact
even in virus infected bPAECs.
3.5. Impedance of bPAEC monolayers is unaltered by exposure to recombinant BTV proteins
The effect of individual recombinant BTV proteins on bPAEC monolayers was assessed by
adding each recombinant protein to the culture medium so that it would contact the luminal
surface of the bPAEC monolayer. None of the proteins had any significant effect on the
impedance of the treated monolayers, nor on the microscopic appearance of the monolayers
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(data not shown), confirming luminal application of these proteins caused neither cell death or
had any obvious paracrine effect on EC barrier integrity.
3. Discussion
We evaluated the effect of BTV infection on monolayers of bPAECs. The data confirm that
BTV-infected bPAECs exhibit a delayed decrease in monolayer impedance, and this decrease
is highly correlated with the onset of cell death. The data further confirm that the adherens
junctions of BTV-infected ECs remain intact throughout the course of infection, and that
individual recombinant BTV proteins did not cause cell death or alter bPAEC monolayer
impedance. We conclude, therefore, that the change in BTV-infected bPAEC monolayer
impedance, and thus permeability, is due largely to cell death. The precise mechanism of virus-
induced cell death, whether apoptosis or necrosis, was not determined. Our conclusions differ
from those of another recent investigation wherein the authors concluded that BTV infection
caused an immediate (after 2 hours) loss of resistance of human EC monolayers (Chiang et
al., 2006). The authors of this study further concluded that loss of monolayer resistance and
increased permeability were due to the redistribution of EC adherens junctions within the
infected monolayers, which in turn would lead to increased paracellular permeability. A
potential explanation for the different outcomes of the two studies is the different inocula that
were used; specifically, we used partially purified virus that was separated from soluble, cell-
derived mediators whereas an unpurified virus inoculum was used in the prior studies. The
presence or absence of inflammatory mediators in the virus inoculum clearly can influence
both the onset and mechanism of EC death (DeMaula et al., 2001), thus the use of a purified
virus inoculum is essential to accurate characterization of the effects of virus infection alone
on EC monolayer permeability and integrity.
The data obtained in the current study are consistent with the proposed pathogenesis of
bluetongue in ruminants (MacLachlan et al., 2009). Specifically, it is hypothesized that direct
virus-mediated injury results in EC destruction and subsequent vascular thrombosis and tissue
infarction during the acute phase of BTV infection of susceptible animals, whereas the
widespread edema that occurs in the terminal phases of bluetongue, African horse sickness and
other virus-induced hemorrhagic fevers is likely the result of EC contraction and increased
paracellular permeability induced by host-derived proinflammatory mediators such as TNF
(Gowen and Holbrook, 2008; MacLachlan et al., 2009). This conclusion is consistent with the
tropism of these viruses for ECs, macrophages and dendritic cells (Barratt-Boyes et al.,
1992; Brewer and MacLachlan, 1994; Drew et al., 2010; Ellis et al., 1993; Hemati et al.,
2009; Whetter et al., 1989), which are all potent sources of pro-inflammatory cytokine
mediators such as TNF, and by ultrastructural studies that have clearly shown restricted virus
infection of ECs but more widespread EC injury with accompanying edema in the tissues of
horses with African horse sickness and white-tailed deer with bluetongue (Gomez-
Villamandos et al., 1999; Howerth and Tyler, 1988; Laegreid et al., 1992). However, the
pathogenesis of EC injury and dysfunction in bluetongue and other orbiviral hemorrhagic
fevers is likely to be highly complex, and in vivo studies clearly will ultimately be required to
confirm the significance of these in vitro findings.
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Fig. 1.
Replication of BTV in bPAECs. Immunofluorescence staining of VP7 (red) over time (200x).
Note diffuse cytoplasmic staining of VP7 throughout the monolayer by 12 hours after infection,
and that patchy areas of the monolayer are devoid of cells by 24 hours (cytopathic effect).
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Fig. 2.
Effects of recombinant bovine TNF-α (rbTNF-α) and Triton X-100 on bPAEC monolayer
impedance and cell viability. (A) Immediate and sustained loss of bPAEC monolayer
impedance following Triton X-100 treatment, as compared to vehicle control. (B) Decreasing
and sustained decrease in bPAEC monolayer impedance beginning at 2 hours following
treatment with rbTNF – α. Individual treatments were each done 4 times in 6 replicate wells.
The data are presented as the mean of replicate wells +/− the SD of one representative
experiment. * designates significant (p < 0.05) difference between the treated and vehicle
control well at 6 hours after treatment. (C) Assessment of cell viability in bPAEC monolayers
at 6 hours treatment with either rbTNF-α, Triton X-100, or vehicle control. There was no
statistical difference in the ratios of cell death between the vehicle and TNF – α treated
monolayers, whereas the ratio of cell death of the Triton X-100 treated bPAECs was
significantly increased. Each treatment was carried out 5 times in 3 replicate wells. The data
are reported as the mean of the combined ratios of cell death of treated as compared to control
monolayers, +/− the SD of one experiment. * represents significant (p < 0.05) differences
between the treatment group. (D) Effect of Triton X-100 on bPAEC at 6 hours after treatment.
Phase contrast image (200X) demonstrating widespread cytopathic effect and loss of
monolayer integrity. (E) Immunofluorescence staining of VE – cadherin (green) and actin (red)
in bPAEC at 6 hours after TNF – α treatment (1000X). The TNF-treated bPAECs have
prominent intercellular gaps (white arrowheads) and redistribution of VE – cadherin (white
arrows) as compared to the vehicle-treated control.
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Fig. 3.
Effect of BTV infection (m.o.i. 5) on impedance and viability of bPAEC monolayers. (A)
Impedance of BTV-infected monolayers is significantly decreased as compared to uninfected
monolayers beginning at 12 hours after infection, and continuing thereafter. Each treatment
was done 4 times in 6 replicate wells. The data are presented as the mean of replicate wells +/
− the SD. * designates significant (p < 0.05) difference between the time point and the 0hr and
6hr time points. (B) Cell death ratio of BTV-infected monolayers increases over time,
beginning at 12 hours after infection. Each treatment was done 5 times in 3 replicate wells, and
the data are presented as the means of the ratios of infected to control +/− SD. * indicates
significant difference (p < 0.05) (C) Phase contrast microscopy (200 X) illustrates cytopathic
effect in the BTV-infected bPAEC monolayers. Substantial holes are present in the infected
monolayers by 18 hours after infection.
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Fig. 4.
Effect of BTV infection (m.o.i 5) on bPAEC intercellular junctions. Immunofluorescence
staining for VE – cadherin (green) and BTV core protein VP7 (red) (1000X). The intercellular
junctions of infected ECs remain intact at 6, 12, and 18 hours after infection of the bPAEC
monolayers (white arrow heads). At 24 hours cytopathic effect is advanced, however
intercellular junctions are both intact (white arrow head) in surviving ECs and have gaps (white
arrow) formed between adjacent cells. There is a substantial defect in the monolayer where
dead cells have sloughed (white asterisks).
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